Standout Papers

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder... 2015 2026 2018 2022 2.9k
  1. Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder (2019)
    Takashi Yamamura, Ingo Kleiter et al. New England Journal of Medicine
  2. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders (2015)
    Dean M. Wingerchuk, Brenda Banwell et al. Neurology
  3. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing (2018)
    Sven Jarius, Friedemann Paul et al. Journal of Neuroinflammation
  4. Ravulizumab in Aquaporin‐4–Positive Neuromyelitis Optica Spectrum Disorder (2023)
    Sean J. Pittock, Michael Barnett et al. Annals of Neurology

Immediate Impact

20 from Science/Nature 82 standout
Sub-graph 1 of 20

Citing Papers

mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
2024 Standout
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
1 intermediate paper

Works of J. de Sèze being referenced

Autophagy in neuroinflammatory diseases
2017
Efficacy of rituximab in refractory neuromyelitis optica
2015

Author Peers

Author Last Decade Papers Cites
J. de Sèze 9715 7550 3372 469 14.9k
Ichiro Nakashima 9558 7829 3266 370 13.8k
Robert Zivadinov 12436 5569 3362 575 18.8k
Brenda Banwell 8941 5752 2596 260 12.5k
Bianca Weinstock‐Guttman 14931 5527 3413 509 19.9k
Bernard M.J. Uitdehaag 11716 3960 2937 453 18.1k
Friedemann Paul 11742 8500 3538 603 21.2k
Patrick Vermersch 6509 4493 2263 380 13.2k
Markus Reindl 6391 6126 2435 249 12.9k
Tanuja Chitnis 10666 5515 2835 355 16.8k
Maria A. Rocca 17399 6525 3564 597 24.9k

All Works

Loading papers...

Rankless by CCL
2026